Sugen falls as casualty of Pfizer-Pharmacia merger

被引：2

|

作者：

Garber, K

机构：

来源：

NATURE BIOTECHNOLOGY | 2003年 / 21卷 / 07期

关键词：

D O I：

10.1038/nbt0703-722

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：722 / 723

页数：2

相关论文

共 50 条

[1] Sugen falls as casualty of Pfizer–Pharmacia merger
Ken Garber
Nature Biotechnology, 2003, 21 : 722 - 723
[2] Pfizer-Pharmacia merger finalized
不详
CHEMICAL ENGINEERING PROGRESS, 2003, 99 (07) : 17 - 17
[3] Pfizer-Pharmacia merger bodes ill for biotech?
Fletcher, L
NATURE BIOTECHNOLOGY, 2002, 20 (09) : 855 - 858
[4] Pfizer-Pharmacia: the postmerger
Wiggins, P
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (11) : 1761 - 1763
[5] Pfizer-Pharmacia: the smart fit for the future
Wiggins, WP
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (01) : 1 - 3
[6] Kalexsyn Inc.: A new company from the Pfizer-Pharmacia merger.
Zimmermann, DC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U1168 - U1169
[7] Contract firms skittish on Pfizer-Pharmacia deal
Mullin, R
CHEMICAL WEEK, 2002, 164 (29) : 27 - 27
[8] Pfizer-Pharmacia deal will accelerate Monsanto spin-off
Westervelt, R
CHEMICAL WEEK, 2002, 164 (29) : 9 - 9
[9] Pfizer, Pharmacia merger gets FTC nod
不详
TCE, 2003, (743): : 4 - 4
[10] Pfizer–Pharmacia merger bodes ill for biotech?
Fletcher L.
Nature Biotechnology, 2002, 20 (9) : 857 - 858

← 1 2 3 4 5 →